Testing a New Therapy for Trichotillomania

September 27, 2021 updated by: Douglas Woods, University of Wisconsin, Milwaukee

Acceptance Enhanced Behavior Therapy for Trichotillomania

This study will test the effectiveness of a new behavioral therapy for adults with trichotillomania (compulsive hair pulling).

Study Overview

Detailed Description

Trichotillomania (TTM) is a disorder in which people compulsively pull out their own hair. Treatments for TTM sometimes do not have long-term effectiveness. Acceptance and commitment therapy (ACT) is a therapeutic approach thought to have longer lasting effects than standard cognitive behavioral therapy (CBT) approaches, because ACT focuses on accepting thoughts and behaviors as opposed to changing them. Previous research indicates that a combination of ACT and habit reversal behavioral therapy is more effective than no treatment. This study will test whether a combination of ACT and behavioral therapy, called acceptance enhanced behavioral therapy (AEBT), is more effective than the current standard treatment for TTM.

Participation in this study will last 12 weeks, and follow-up assessments will last for 6 months. At study entry, participants will complete a brief intelligence test and an in-person interview about their medical history, psychiatric history, and hair pulling. At their second visit, participants will have digital pictures taken of their hair-pulling sites and complete two computer tasks measuring their response inhibition and cognitive flexibility. After the second visit, participants will be randomly assigned to receive either AEBT or psychoeducation and supportive therapy (PST)-a standard treatment for TTM. Both treatments will involve ten 1-hour sessions completed over 12 weeks. Assessments of participants will occur after 6 weeks of treatment, at treatment completion, and after 6 months. These assessments will measure treatment effectiveness, based on several clinical scales and measures of TTM symptoms. Participants who receive PST during this study will be offered AEBT afterward.

Study Type

Interventional

Enrollment (Actual)

85

Phase

  • Phase 2

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Wisconsin
      • Milwaukee, Wisconsin, United States, 53211
        • Marquette University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Current DSM-IV diagnosis of trichotillomania
  • Massachusetts General Hospital Hair Scale score greater than 12
  • Wechsler Test of Adult Reading score greater than 85
  • Fluent in English
  • Outpatient status
  • Agreement to not alter the dosage of any psychotropic medication throughout the course of the study, or, if such a dosage change is required, understanding that the participant will continue to receive treatment, and data will continue to be collected on him or her
  • Individuals who eat their hair after pulling will be eligible for participation only after they have received a physical exam from their primary care physician to determine whether there is any gastrointestinal blockage due to hair pulling, which would require more immediate clinical care.

Exclusion Criteria:

  • Diagnosis of bipolar disorder, psychotic disorder, mental retardation, pervasive developmental disorder, or current substance dependence (with the exception of nicotine dependence)
  • Current mood or anxiety disorder with an active suicide risk
  • Currently receiving psychotherapy for trichotillomania or another psychiatric condition
  • Initiation or change in the dosage of any psychotropic medication for up to 8 weeks preceding participation in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: 1
Participants will receive acceptance enhanced behavior therapy (AEBT) for trichotillomania (TTM).
Ten 1-hour sessions over 12 weeks, enhancing awareness of hair-pulling behavior and teaching strategies to deal with hair pulling
Other Names:
  • Behavior Therapy
  • ACT
  • Acceptance and Commitment Therapy
  • Habit Reversal
ACTIVE_COMPARATOR: 2
Participants will receive psychoeducation and supportive therapy (PST) for TTM.
Ten 1-hour sessions over 12 weeks, teaching the participant about hair pulling and discussing how hair pulling affects those who do it
Other Names:
  • Supportive Therapy
  • Psychoeducation

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Clinical Global Impressions-Improvement Scale
Time Frame: Measured after 6 weeks, 12 weeks, and 6 months
Measured after 6 weeks, 12 weeks, and 6 months

Secondary Outcome Measures

Outcome Measure
Time Frame
Massachusetts General Hospital Hairpulling Scale
Time Frame: Measured at screening, baseline, and after 6 weeks, 12 weeks, and 6 months
Measured at screening, baseline, and after 6 weeks, 12 weeks, and 6 months
National Institute of Mental Health (NIMH) Trichotillomania Severity and Impairment Scales
Time Frame: Measured at screening, baseline, and after 6 weeks, 12 weeks, and 6 months
Measured at screening, baseline, and after 6 weeks, 12 weeks, and 6 months
Clinical Global Impressions-Severity Scale
Time Frame: Measured at screening, baseline, and after 6 weeks, 12 weeks, and 6 months
Measured at screening, baseline, and after 6 weeks, 12 weeks, and 6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Douglas W. Woods, PhD, Marquette University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2009

Primary Completion (ACTUAL)

October 1, 2013

Study Completion (ACTUAL)

November 30, 2015

Study Registration Dates

First Submitted

March 30, 2009

First Submitted That Met QC Criteria

March 30, 2009

First Posted (ESTIMATE)

March 31, 2009

Study Record Updates

Last Update Posted (ACTUAL)

October 5, 2021

Last Update Submitted That Met QC Criteria

September 27, 2021

Last Verified

September 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • R01MH080966 (NIH)
  • DATR A2-AIR
  • 1R01MH080966 (NIH)
  • NIMH-3065236

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Trichotillomania

Clinical Trials on Acceptance enhanced behavior therapy (AEBT)

3
Subscribe